List of Tables
Table 1. Global Allergy Immunotherapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Manufacturers of Subcutaneous Immunotherapy
Table 3. Major Manufacturers of Sublingual Immunotherapy
Table 4. Global Allergy Immunotherapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global Allergy Immunotherapy Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
Table 6. Global Allergy Immunotherapy Sales by Region (2017-2022) & (K Units)
Table 7. Global Allergy Immunotherapy Sales Forecast by Region (2023-2028) & (K Units)
Table 8. Global Allergy Immunotherapy Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Allergy Immunotherapy Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 10. Global Allergy Immunotherapy Sales by Manufacturer (2017-2022) & (K Units)
Table 11. Global Allergy Immunotherapy Sales Share by Manufacturer (2017-2022)
Table 12. Allergy Immunotherapy Revenue by Manufacturer (2017-2022) & (US$ Million)
Table 13. Allergy Immunotherapy Revenue Share by Manufacturer (2017-2022)
Table 14. Key Manufacturers Allergy Immunotherapy Price (2017-2022) & (USD/Unit)
Table 15. Ranking of Global Top Allergy Immunotherapy Manufacturers by Revenue (US$ Million) in 2021
Table 16. Global Allergy Immunotherapy Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 17. Global Allergy Immunotherapy by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Allergy Immunotherapy as of 2021)
Table 18. Allergy Immunotherapy Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Allergy Immunotherapy Product Type
Table 20. Date of International Manufacturers Enter into Allergy Immunotherapy Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. ALK-Abello Corporation Information
Table 23. ALK-Abello Description and Business Overview
Table 24. ALK-Abello Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 25. ALK-Abello Allergy Immunotherapy Product
Table 26. ALK-Abello Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Product in 2021
Table 27. ALK-Abello Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Application in 2021
Table 28. ALK-Abello Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Geographic Area in 2021
Table 29. ALK-Abello Recent Development
Table 30. Stallergenes Greer Corporation Information
Table 31. Stallergenes Greer Description and Business Overview
Table 32. Stallergenes Greer Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 33. Stallergenes Greer Allergy Immunotherapy Product
Table 34. Stallergenes Greer Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Product in 2021
Table 35. Stallergenes Greer Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Application in 2021
Table 36. Stallergenes Greer Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Geographic Area in 2021
Table 37. Stallergenes Greer Recent Development
Table 38. Merck Corporation Information
Table 39. Merck Description and Business Overview
Table 40. Merck Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 41. Merck Allergy Immunotherapy Product
Table 42. Merck Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Product in 2021
Table 43. Merck Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Application in 2021
Table 44. Merck Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Geographic Area in 2021
Table 45. Merck Recent Development
Table 46. Allergy Therapeutics Corporation Information
Table 47. Allergy Therapeutics Description and Business Overview
Table 48. Allergy Therapeutics Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 49. Allergy Therapeutics Allergy Immunotherapy Product
Table 50. Allergy Therapeutics Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Product in 2021
Table 51. Allergy Therapeutics Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Application in 2021
Table 52. Allergy Therapeutics Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Geographic Area in 2021
Table 53. Allergy Therapeutics Recent Development
Table 54. HAL Corporation Information
Table 55. HAL Description and Business Overview
Table 56. HAL Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. HAL Allergy Immunotherapy Product
Table 58. HAL Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Product in 2021
Table 59. HAL Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Application in 2021
Table 60. HAL Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Geographic Area in 2021
Table 61. HAL Recent Development
Table 62. Holister Stier Corporation Information
Table 63. Holister Stier Description and Business Overview
Table 64. Holister Stier Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Holister Stier Allergy Immunotherapy Product
Table 66. Holister Stier Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Product in 2021
Table 67. Holister Stier Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Application in 2021
Table 68. Holister Stier Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Geographic Area in 2021
Table 69. Leti Corporation Information
Table 70. Leti Description and Business Overview
Table 71. Leti Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Leti Allergy Immunotherapy Product
Table 73. Leti Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Product in 2021
Table 74. Leti Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Application in 2021
Table 75. Leti Allergy Immunotherapy Sales Proportion of Allergy Immunotherapy by Geographic Area in 2021
Table 76. Global Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 77. Global Allergy Immunotherapy Sales Forecast by Type (2023-2028) & (K Units)
Table 78. Global Allergy Immunotherapy Revenue by Type (2017-2022) & (US$ Million)
Table 79. Global Allergy Immunotherapy Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 80. Global Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 81. Global Allergy Immunotherapy Sales Forecast by Application (2023-2028) & (K Units)
Table 82. Global Allergy Immunotherapy Revenue by Application (2017-2022) & (US$ Million)
Table 83. Global Allergy Immunotherapy Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 84. North America Allergy Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 85. North America Allergy Immunotherapy Sales by Country (2023-2028) & (K Units)
Table 86. North America Allergy Immunotherapy Revenue by Country (2017-2022) & (US$ Million)
Table 87. North America Allergy Immunotherapy Revenue by Country (2023-2028) & (US$ Million)
Table 88. North America Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 89. North America Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 90. Asia-Pacific Allergy Immunotherapy Sales by Region (2017-2022) & (K Units)
Table 91. Asia-Pacific Allergy Immunotherapy Sales by Region (2023-2028) & (K Units)
Table 92. Asia-Pacific Allergy Immunotherapy Revenue by Region (2017-2028) & (US$ Million)
Table 93. Asia-Pacific Allergy Immunotherapy Revenue by Region (2023-2028) & (US$ Million)
Table 94. Asia-Pacific Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 95. Asia-Pacific Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 96. Europe Allergy Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 97. Europe Allergy Immunotherapy Sales by Country (2023-2028) & (K Units)
Table 98. Europe Allergy Immunotherapy Revenue by Country (2017-2022) & (US$ Million)
Table 99. Europe Allergy Immunotherapy Revenue by Country (2023-2028) & (US$ Million)
Table 100. Europe Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 101. Europe Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 102. Latin America Allergy Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 103. Latin America Allergy Immunotherapy Sales by Country (2023-2028) & (K Units)
Table 104. Latin America Allergy Immunotherapy Revenue by Country (2017-2022) & (US$ Million)
Table 105. Latin America Allergy Immunotherapy Revenue by Country (2023-2028) & (US$ Million)
Table 106. Latin America Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 107. Latin America Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 108. Middle East and Africa Allergy Immunotherapy Sales by Country (2017-2022) & (K Units)
Table 109. Middle East and Africa Allergy Immunotherapy Sales by Country (2023-2028) & (K Units)
Table 110. Middle East and Africa Allergy Immunotherapy Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Allergy Immunotherapy Revenue by Country (2023-2028) & (US$ Million)
Table 112. Middle East and Africa Allergy Immunotherapy Sales by Type (2017-2022) & (K Units)
Table 113. Middle East and Africa Allergy Immunotherapy Sales by Application (2017-2022) & (K Units)
Table 114. Allergy Immunotherapy Key Raw Materials, Industry Status and Trend
Table 115. Allergy Immunotherapy Key Raw Materials and Upstream Suppliers
Table 116. Allergy Immunotherapy Clients Status and Trend
Table 117. Allergy Immunotherapy Typical Clients
Table 118. Allergy Immunotherapy Distributors
Table 119. Allergy Immunotherapy Market Trends
Table 120. Allergy Immunotherapy Market Drivers
Table 121. Allergy Immunotherapy Market Challenges
Table 122. Allergy Immunotherapy Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Allergy Immunotherapy Product Picture
Figure 2. Global Allergy Immunotherapy Sales Market Share by Type in 2021 & 2028
Figure 3. Subcutaneous Immunotherapy Product Picture
Figure 4. Sublingual Immunotherapy Product Picture
Figure 5. Global Allergy Immunotherapy Sales Market Share by Application in 2021 & 2028
Figure 6. Allergic Rhinitis Examples
Figure 7. Allergic Asthma Examples
Figure 8. Others Examples
Figure 9. Allergy Immunotherapy Report Years Considered
Figure 10. Global Allergy Immunotherapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Allergy Immunotherapy Market Size 2017-2028 (US$ Million)
Figure 12. Global Allergy Immunotherapy Sales 2017-2028 (K Units)
Figure 13. Global Allergy Immunotherapy Market Size Market Share by Region: 2022 Versus 2028
Figure 14. Global Allergy Immunotherapy Sales Market Share Forecast by Region (2017-2028)
Figure 15. Global Allergy Immunotherapy Revenue Market Share by Region (2017-2028)
Figure 16. Global Allergy Immunotherapy Sales Share by Manufacturer in 2021
Figure 17. Allergy Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Allergy Immunotherapy Sales Market Share Forecast by Type (2017-2028)
Figure 19. Global Allergy Immunotherapy Revenue Market Share Forecast by Type (2017-2028)
Figure 20. Allergy Immunotherapy Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)
Figure 21. Global Allergy Immunotherapy Sales Market Share Forecast by Application (2017-2028)
Figure 22. Global Allergy Immunotherapy Revenue Market Share Forecast by Application (2017-2028)
Figure 23. Allergy Immunotherapy Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)
Figure 24. North America Allergy Immunotherapy Revenue 2017-2028 (US$ Million)
Figure 25. North America Allergy Immunotherapy Sales Market Share by Type (2017-2022)
Figure 26. North America Allergy Immunotherapy Sales Market Share by Application (2017-2022)
Figure 27. Asia-Pacific Allergy Immunotherapy Revenue 2017-2028 (US$ Million)
Figure 28. Asia-Pacific Allergy Immunotherapy Sales Market Share by Region (2017-2028)
Figure 29. Asia-Pacific Allergy Immunotherapy Revenue Market Share by Region (2017-2028)
Figure 30. Asia-Pacific Allergy Immunotherapy Sales Market Share by Type (2017-2022)
Figure 31. Asia-Pacific Allergy Immunotherapy Sales Market Share by Application (2017-2022)
Figure 32. Europe Allergy Immunotherapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 33. Europe Allergy Immunotherapy Sales Market Share by Country (2017-2028)
Figure 34. Europe Allergy Immunotherapy Revenue Market Share by Country (2017-2028)
Figure 35. Europe Allergy Immunotherapy Sales Market Share by Type (2017-2022)
Figure 36. Europe Allergy Immunotherapy Sales Market Share by Application (2017-2022)
Figure 37. Latin America Allergy Immunotherapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 38. Latin America Allergy Immunotherapy Sales Market Share by Country (2017-2028)
Figure 39. Latin America Allergy Immunotherapy Revenue Market Share by Country (2017-2022)
Figure 40. Latin America Allergy Immunotherapy Sales Market Share by Type (2017-2022)
Figure 41. Latin America Allergy Immunotherapy Sales Market Share by Application (2017-2022)
Figure 42. Middle East and Africa Allergy Immunotherapy Revenue Growth Rate 2017-2028 (US$ Million)
Figure 43. Middle East and Africa Allergy Immunotherapy Sales Market Share by Country (2017-2028)
Figure 44. Middle East and Africa Allergy Immunotherapy Revenue Market Share by Country (2017-2028)
Figure 45. Middle East and Africa Allergy Immunotherapy Sales Market Share by Type (2017-2022)
Figure 46. Middle East and Africa Allergy Immunotherapy Sales Market Share by Application (2017-2022)
Figure 47. Allergy Immunotherapy Supply Chain (Upstream and Downstream Market)
Figure 48. Global Production Market Share of Allergy Immunotherapy Raw Materials by Region in 2021
Figure 49. Allergy Immunotherapy Distribution Channels
Figure 50. Global Allergy Immunotherapy Percentage 2017-2028: Indirect Sales VS Direct Sales
Figure 51. Global Allergy Immunotherapy Percentage 2017-2028: Online Sales VS Offline Sales
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation